Researchers have used CRISPR-Cas to edit the genes of contaminating proteins in mammalian cells used to produce recombinant-protein drugs, which could reduce costs and strengthen quality.
List view / Grid view
Technical University of Denmark
An international team of researchers has developed a computational resource that provides a 3D view of genes, proteins and metabolites involved in human metabolism...
Circumventing evolution in cell factories can pave the way for commercialising new biobased chemicals to large-scale.